December 5, 2011Date Released: 5 December 2011
CASE CCC IN THE NEWS
University Hospitals Seidman Cancer Center Tests Novel Drug That Makes Brain Tumors Glow Hot Pink
MedWorks Clinic Spotted Cancer, Saved Life: Holiday Spirit
MARK YOUR CALENDARSCancer Center Seminar Series: Defining Novel Tumor Suppressor-Oncogene Interactions in Mammary Cell Transformation
Friday, December 9
Please join us Friday, December 9 at the next Cancer Center Seminar Series featuring Mark W. Jackson, PhD. Dr. Jackson, Assistant Professor of Pathology at CWRU, will present Defining Novel Tumor Suppressor-Oncogene Interactions in Mammary Cell Transformation.
The Jackson laboratory focuses on genetic events that contribute to breast hyperplasia. They have developed a breast cancer model that starts with normal human mammary epithelial cells (HMECs), and utilizes genetic alterations associated with breast cancer to transform the HMEC to a cancerous state. Using this model, they can interrogate the contribution of breast specific tumor-suppressive signaling and define how oncogene activation dismantles these suppressive signals to drive breast cancer development and progression. Current areas of focus include identifying novel endogenous regulators of HMEC transformation, and how exogenous microenvironmental factors (TGF-beta, Oncostatin M, and Interferon signaling) influence the transformed phenotype.Laser Capture Microdissection Service Replacement System Demonstrations
The second Laser Microdissection demonstration takes place Tuesday, December 6 and Wednesday, December 7. Leica will demonstrate their LMD 6500 system. All are welcome to drop by any time between 9 am and 5 pm to check out the system. Exclusive blocks of one-hour, hands-on time with the Leica trainer may be scheduled by contacting Patrick Leahy at firstname.lastname@example.org or (216)368-0761.
ANNOUNCEMENTSASH Annual Meeting
The upcoming American Society of Hematology (ASH) Annual Meeting, December 10-13, will feature updates on groundbreaking research. We are pleased to have research conducted by Case CCC members well represented at the poster sessions. In addition, Drs. Jaroslaw Maciejewski and Clark Distelhorst are invited speakers, and Drs. Raymond Tiu, Yogen Saunthararajah, Hillard Lazarus, Anjali Advani, Brian Bolwell, Mikkael Sekeres, and Alvin Schmaier will be serving as session moderators. Click hereto view a listing of all Cancer Center presentations and abstracts.
Congratulations to all participants.
FUNDING OPPORTUNITIESAACI Translational Cancer Research Fellowship
The Case CCC is accepting nominations for the AACI Translational Cancer Research Fellowship. The intent of the fellowship is to provide additional support to individuals who are engaged in any area of clinical and/or translational cancer research in order to further the development of their careers and enhance their future success in an academic discipline. The AACI fellowship will provide a one-year non-renewable grant to support post-doctoral training to individuals who have completed at least one year of training in any field of oncology and have at least one year of training remaining at an AACI member institution.
Interested candidates should forward a letter of support from their mentor and their biosketch to Gillian Todd by Monday, December 12. We may nominate ONE candidate from CWRU/UH, and ONE from the Cleveland Clinic.
The Case CCC is accepting nominations for the Mary Kay Foundation Translational Cancer Research Program, which offers innovative grants for translational research in ovarian, uterine, breast, or cervical cancer. Applications must be submitted by one Principal Investigator, selected by the Institution. Only ONE grant application will be accepted from each accredited medical school and schools of public health in the United States.
Interested candidates should forward a one-paragraph description and their biosketch to Gillian Todd by Tuesday, December 13.
The Case CCC is accepting nominations for the Damon Runyon Clinical Investigator Award, which supports young physician-scientists conducting patient-oriented cancer research. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators.
Interested candidates should forward a one-page letter of intent of proposal and their biosketch to Gillian Todd by Wednesday, December 14.
The National Center of Regenerative Medicine (NCRM) is accepting proposals for funding of Stem Cell-related Pilot Projects. NCRM can provide two $35,000 grants this year to promote new projects in stem cell research and an additional $10,000 can be requested from the CTSC to use one of their approved facilities. In addition to providing seed money for new research ideas, priority will be given to projects that involve multiple institutions, have robust experimental plans and when completed lead to additional funding opportunities. Projects must have a clinical and/or commercial direction though it may be more rudimentary.
The Society of Surgical Oncology (SSO) is now accepting applications for its 2012 Clinical Investigator Awards. The purpose of these awards is to promote patient-oriented research conducted by surgical oncologists in clinical and translational science. Applicants must be surgical oncologists within 10 years of completion of training and be full SSO members.
The AACR-Genentech BioOncology Fellowship for Cancer Research on the HER Family Pathway represents a joint effort to encourage and support postdoctoral and clinical research fellows who are in the first 5 years of their fellowship training (at the start of the grant term) to conduct cancer research on the HER family pathway and establish successful career paths in this field. Proposed research projects are restricted to basic, translational, clinical, or epidemiological projects that substantially advance the field of cancer research on the HER family pathway.
The AACR Clinical and Translational Cancer Research Fellowships are open to Postdoctoral and Clinical Research Fellows working at an academic, medical, or research institution who will be in the first 5 years of their postdoctoral training at the start of the grant term. Proposed research projects may be in any area of clinical and/or translational cancer research.
SAIC-Frederick is pleased to announce a new solicitation available in support of The Cancer Genome Atlas (TCGA) Program. The Cancer Genome Atlas is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. This funding is made available under Congressional appropriated funding and also the American Recovery and Reinvestment Act of 2009 (Recovery Act), Pub. L. No. 111-5.
SAIC Frederick hopes to receive proposals from institutions and established network sites that currently collect high quality biospecimens. TCGA TSS awardees will either have an on-site biorepository (located in the same institution as the specimen collection) or demonstrate capability to collect, short-term store, and ship high quality biospecimens to an appropriate biorepository. SAIC-Frederick is hopeful that many sites will meet the qualifications and would find it attractive to participate in the specimen collection portion of TCGA.
The Caring for Carcinoid Foundation-AACR Grants for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research represent a joint effort to promote and support innovative cancer research. These grants are available to independent junior and senior investigators to develop and study new ideas and approaches that have direct application and relevance to carcinoid tumors or pancreatic neuroendocrine tumors. Proposed research may be in any discipline of basic, translational, clinical or epidemiological cancer research.
Through its Young Investigator Award Program, the Children's Tumor Foundation seeks scientific and clinical research applications that apply novel and innovative research ideas aimed at accelerating progress toward improved management of individuals affected with NF1, NF2 and schwannomatosis.
NSF, in collaboration with the Health Information Technology (IT) Portfolio at the Agency for Healthcare Research and Quality (AHRQ), will accept and review investigator-initiated proposals that address systems modeling in health services research. The Service Enterprise Systems program in the Civil, Mechanical, and Manufacturing Innovation (CMMI) division of the Engineering Directorate will be the lead program on this interdisciplinary topic. Through this partnership, NSF and AHRQ look to foster new collaborations among health services researchers and industrial and systems engineers with a specific emphasis on the supportive role of health IT.
The Leukemia & Lymphoma Society (LLS) funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application. TheTranslational Research Program (TRP) puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma. The goal of translational research is to reduce the time between laboratory findings and actual treatment.
NCI CANCER BULLETINNovember 29, 2011
**All events are open to anyone interested in attending
Skeletal Research Center
Skeletal Research Center
Cancer Biology Special Seminar
Hematology and Oncology Division Research Conference
Immunology Invited Speaker Seminar Series
Hematology and Oncology Research Conference Special Presentation
Cancer Center Research in Progress Seminar canceled
Hematology/Oncology Fellows Conference canceled
Taussig Cancer Institute Grand Rounds canceled
Cancer Center Seminar Series
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ADDITIONAL UPCOMING SEMINARS & EVENTS
Office of Cancer Centers Learning Series Webinar: Opportunity for CTSU Support for Collaborative Multi-Center Phase 2 Trials Led by NCI-Designated Cancer Centers and SPOREs
PREVIOUSLY ANNOUNCED OPPORTUNITIES
American Medical Association Seed Grant Research Program
2012 Lasker Awards
NIH BULLETIN – Notices and Funding Opportunities
Cancer Education Grants Program (R25)(PAR-12-049)
UPDATE to American Reinvestment and Recovery Act (ARRA): AHRQ Grant Policy Notice Removing Expanded Authorities and No Cost Extensions for AHRQ ARRA Grants (NOT-HS-12-002)
Research Centers in Primary Care Practice Based Research and Learning (P30)(RFA-HS-12-002)
Small Grants Program for Cancer Epidemiology (R03)(PAR-12-039)
Frequently Asked Questions for RFA-MH-12-130 - OppNet's Basic Research on Decision Making: Cognitive, Affective, and Developmental Perspectives (R01) (NOT-OD-12-019)
Administrative Supplements for U.S. - China Biomedical Collaborative Research on Cancer, Mental Health, Allergy, Immunology, and Infectious Diseases including HIV/AIDS and its Co-morbidities (NOT-CA-12-002)
Notice of Correction of Award Budget for PAR-12-010, NIH Competitive Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (R01) (NOT-CA-12-005)
Limited Competition - Women's Interagency HIV Study (WIHS-V) (U01) (RFA-AI-12-002)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.